SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update

FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4

BYSI

Related stories